<DOC>
	<DOCNO>NCT01288326</DOCNO>
	<brief_summary>The study conduct Europe . The aim observational study assess glycaemic control use liraglutide normal clinical practice condition Belgium .</brief_summary>
	<brief_title>Observational Study Effectiveness Safety Liraglutide Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes Insufficiently control 3 month treatment OADs ( oral antidiabetic drug ) Previously treat liraglutide Hypersensitivity liraglutide excipients ( Disodium phosphate dihydrate , propylene glycol , phenol , water injection ) Pregnant , breast feeding intention become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>